ArticleBMJ open2019

Accelerated, Dose escalated, Sequential Chemoradiotherapy in Non-small-cell lung cancer (ADSCaN): a protocol for a randomised phase II study.

Matthew Q F Hatton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.